LEDERSKAB
Definition af nye muligheder
Vores lederteam driver os frem for at udvikle det ekstraordinære og være førende inden for sundhedsteknologi. Deres perspektiver og nye ideer inspirerer os til at løse verdens sundhedsudfordringer og hjælper os ikke blot med at skabe banebrydende nye behandlinger, men også med at profilere vores store positive rolle i samfundet.
Geoffrey S. Martha
Chairman & CEO
Scott Cundy
SVP & Chief Quality Officer
Que Dallara
EVP & President Diabetes Operating Unit
Ivan Fong
EVP, General Counsel & Secretary
Alex Gu
SVP & President, Greater China
Bob Hopkins
SVP & Head of Global Strategy
Mike Marinaro
EVP & President, Surgical Operating Unit
Laura Mauri, M.D., M.Sc.
SVP & Chief Scientific, Medical, and Regulatory Officer
Torod Neptune
SVP & Chief Communications
Officer
Karen Parkhill
EVP & Chief Financial Officer
Sean Salmon
EVP & President Cardiovascular Portfolio
Greg Smith
EVP, Global Operations & Supply Chain
Rob ten Hoedt
EVP & President, Global Regions
Brett Wall
EVP & President Neuroscience Portfolio
Ken Washington
SVP & Chief Technology and Innovation Officer
Bob White
EVP & President Medical Surgical Portfolio
Hjælper os med at opfylde vores mission med passion og integritet